Search
Ruzadolane
go.drugbank.com/drugs/DB21444ExperimentalRuzadolane is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.
Darenzepine
go.drugbank.com/drugs/DB19958ExperimentalDarenzepine is a small molecule drug. The usage of the INN stem '-zepine' in the name indicates that Darenzepine is a tricyclic compound. Darenzepine has a monoisotopic molecular weight of 347.16 Da.
Apadoline
go.drugbank.com/drugs/DB20043ExperimentalApadoline is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Apadoline is a analgesic. Apadoline has a monoisotopic molecular weight of 395.2 Da.
Edronocaine
go.drugbank.com/drugs/DB20130ExperimentalEdronocaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Edronocaine is a local anaesthetic. Edronocaine has a monoisotopic molecular weight of 251.19 Da.
Erizepine
go.drugbank.com/drugs/DB20234ExperimentalErizepine is a small molecule drug. The usage of the INN stem '-zepine' in the name indicates that Erizepine is a tricyclic compound. Erizepine has a monoisotopic molecular weight of 290.18 Da.
Tigemonam
go.drugbank.com/drugs/DB20272ExperimentalTigemonam is a small molecule drug. The usage of the INN stem '-monam' in the name indicates that Tigemonam is a monobactam antibiotic. Tigemonam has a monoisotopic molecular weight of 437.03 Da.
Hydroxytetracaine
go.drugbank.com/drugs/DB20319ExperimentalHydroxytetracaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Hydroxytetracaine is a local anaesthetic.
Alimadol
go.drugbank.com/drugs/DB20326ExperimentalAlimadol is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Alimadol is a analgesic. Alimadol has a monoisotopic molecular weight of 281.18 Da.
Nalorphine
go.drugbank.com/drugs/DB11490ExperimentalVet approvedIt is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence. … It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics.
Tovinontrine
go.drugbank.com/drugs/DB16193InvestigationalTovinontrine is under investigation in clinical trial NCT04474314 (A Study of IMR-687 in Subjects With Sickle Cell Disease). … Tovinontrine is an orally administered, highly selective phosphodiesterase 9 (PDE9) small molecule inhibitor.